Josh Jennings
Stock Analyst at TD Cowen
(3.58)
# 2,184
Out of 4,512 analysts
1101
Total ratings
44.8%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $61 | $42.78 | +42.59% | 79 | Jul 14, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $115 | $89.48 | +28.52% | 71 | Jul 13, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $120 | $74.53 | +61.01% | 69 | Jul 11, 2026 | |
| MDT Medtronic | Reiterated: Buy | $119 → $100 | $79.54 | +25.72% | 71 | Jul 10, 2026 | |
| DXCM DexCom | Maintained: Buy | $95 | $73.67 | +28.95% | 39 | Jul 8, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $104 | $89.74 | +15.89% | 71 | Jun 30, 2026 | |
| RCEL AVITA Medical | Maintained: Buy | $5.5 → $12 | $4.00 | +200.00% | 33 | Jun 30, 2026 | |
| AVR Anteris Technologies Global | Reiterated: Buy | $15 | $9.09 | +65.02% | 11 | Jun 29, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $95 → $100 | $85.56 | +16.88% | 51 | Jun 18, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | $6 | $7.65 | -21.57% | 32 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $1.25 | $0.7161 | +74.56% | 46 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $44.94 | +22.39% | 23 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.13 | - | 13 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $18.56 | +56.29% | 23 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $18.83 | +80.56% | 30 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $163 | $150.47 | +8.33% | 21 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.04 | +64.47% | 36 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.29 | +74.95% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $21.52 | -7.06% | 36 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.63 | +207.69% | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.78 | +296.83% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.40 | +127.27% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $252.93 | -1.16% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $20 | $8.99 | +122.59% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $159.44 | +137.71% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $310.76 | +39.98% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.15956 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $5.25 | +1,614.29% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $15.60 | +28.21% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $99 | $89.69 | +10.38% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.262 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.38 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25.46 | $9.93 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $13 | $0.9053 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $130.24 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.44 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $2.84 | n/a | 1 | Mar 18, 2015 |
Boston Scientific
Jul 14, 2026
Maintained: Buy
Price Target: $61
Current: $42.78
Upside: +42.59%
Abbott Laboratories
Jul 13, 2026
Maintained: Buy
Price Target: $115
Current: $89.48
Upside: +28.52%
TransMedics Group
Jul 11, 2026
Maintained: Buy
Price Target: $120
Current: $74.53
Upside: +61.01%
Medtronic
Jul 10, 2026
Reiterated: Buy
Price Target: $119 → $100
Current: $79.54
Upside: +25.72%
DexCom
Jul 8, 2026
Maintained: Buy
Price Target: $95
Current: $73.67
Upside: +28.95%
Edwards Lifesciences
Jun 30, 2026
Reiterated: Buy
Price Target: $104
Current: $89.74
Upside: +15.89%
AVITA Medical
Jun 30, 2026
Maintained: Buy
Price Target: $5.5 → $12
Current: $4.00
Upside: +200.00%
Anteris Technologies Global
Jun 29, 2026
Reiterated: Buy
Price Target: $15
Current: $9.09
Upside: +65.02%
Establishment Labs Holdings
Jun 18, 2026
Rated: Buy
Price Target: $95 → $100
Current: $85.56
Upside: +16.88%
Butterfly Network
Jun 18, 2026
Maintained: Buy
Price Target: $6
Current: $7.65
Upside: -21.57%
Jun 17, 2026
Reiterated: Buy
Price Target: $1.5 → $1.25
Current: $0.7161
Upside: +74.56%
Jun 10, 2026
Reiterated: Buy
Price Target: $55
Current: $44.94
Upside: +22.39%
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $5.13
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $29
Current: $18.56
Upside: +56.29%
Jun 1, 2026
Reiterated: Buy
Price Target: $34
Current: $18.83
Upside: +80.56%
May 29, 2026
Reiterated: Hold
Price Target: $163
Current: $150.47
Upside: +8.33%
May 27, 2026
Reiterated: Buy
Price Target: $5
Current: $3.04
Upside: +64.47%
May 27, 2026
Reiterated: Buy
Price Target: $25
Current: $14.29
Upside: +74.95%
May 18, 2026
Maintained: Hold
Price Target: $20
Current: $21.52
Upside: -7.06%
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.63
Upside: +207.69%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $3.78
Upside: +296.83%
May 8, 2026
Rated: Buy
Price Target: $12 → $10
Current: $4.40
Upside: +127.27%
Apr 23, 2026
Maintained: Buy
Price Target: $250
Current: $252.93
Upside: -1.16%
Jan 23, 2026
Maintained: Buy
Price Target: $27 → $20
Current: $8.99
Upside: +122.59%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $159.44
Upside: +137.71%
Nov 13, 2025
Maintained: Buy
Price Target: $435
Current: $310.76
Upside: +39.98%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.15956
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: $90
Current: $5.25
Upside: +1,614.29%
Nov 6, 2025
Maintained: Buy
Price Target: $20
Current: $15.60
Upside: +28.21%
Nov 5, 2025
Maintained: Hold
Price Target: $104 → $99
Current: $89.69
Upside: +10.38%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.262
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.38
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $25.46
Current: $9.93
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $15 → $13
Current: $0.9053
Upside: n/a
Oct 29, 2020
Maintained: Buy
Price Target: $80
Current: $130.24
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.44
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Maintained: Buy
Price Target: $9
Current: $2.84
Upside: n/a